title: Cabergoline can induce mania with psychotic features in bipolar I disorder: a case report.
abstract: Up to date, only a small evidence of psychosis induced by cabergoline is available in literature. Herein, the case of a 34-year-old bipolar patient treated with cabergoline has been described. Cabergoline is generally a safe and effective method of reducing prolactin levels and it may be associated with psychiatric side effects, including psychotic features.
authors: Department of Psychiatry, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: chiara.rovera@libero.it.
authors: Chiara
authors: C
authors: Rovera
authors: Department of Psychiatry, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
authors: Laura
authors: L
authors: Cremaschi
authors: Manhattan Psychiatric Center, New York, NY, United States; Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, United States.
authors: Amod
authors: A
authors: Thanju
authors: Department of Psychiatry, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
authors: Alessio
authors: A
authors: Fiorentini
authors: Department of Psychiatry, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
authors: Massimo Carlo
authors: MC
authors: Mauri
authors: Department of Psychiatry, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
authors: Marta
authors: M
authors: Serati
authors: Manhattan Psychiatric Center, New York, NY, United States; Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, United States; New York University Medical Center, New York, NY, United States.
authors: Jean Pierre
authors: JP
authors: Lindenmayer
authors: Department of Psychiatry, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
authors: A Carlo
authors: AC
authors: Altamura
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000139:chemically induced*; D000077465:Cabergoline; D004873:Ergolines / Q000009:adverse effects*; D005260:Female; D006801:Humans; D010911:Pituitary Neoplasms / Q000188:drug therapy*; D015175:Prolactinoma / Q000188:drug therapy*; D011605:Psychoses, Substance-Induced / Q000209:etiology*
chemical_list: D000970:Antineoplastic Agents; D004873:Ergolines; D000077465:Cabergoline
keywords: Bipolar Disorder; Cabergoline; Mood Disorders; Prolactinoma; Psychosis